Open AccessP1327: RUXOLITINIB COMBINED WITH GLUCOCORTICOID IN THE FIRST‐LINE TREATMENT OF GRAFT‐VERSUS‐HOST DISEASE IN CHILDREN: A SINGLE CENTER RETROSPECTIVE STUDY
Author(s) -
Chen K.,
Zou B.,
Shao J.B.,
Liu Q.,
Zhang N.,
Fu P.,
Sun X.H.,
Jiang H.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848172.50070.7a
Subject(s) - ruxolitinib , glucocorticoid , medicine , graft versus host disease , hematopoietic stem cell transplantation , retrospective cohort study , single center , adverse effect , immunology , transplantation , bone marrow , myelofibrosis